Christopher Nau, MD
- Specialty: OB/GYN-Maternal and Fetal Medicine, OB/GYN-General
- Languages Spoken: English
Schedule an Appointment:
Biography: Christopher Nau, MD
Titles
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Maternal and Fetal Medicine - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Education
Fellowship | Maternal and Fetal Medicine
Maternal and Fetal Medicine - Women And Infants Hospital Of Rhode Island (2017 - 2020)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - Mount Carmel Medical Center (2013 - 2017)
Medical Education
The Ohio State University College Of Medicine (2009 - 2013)
Undergraduate
The College Of Wooster (2009)
Videos
Watch to find out more about this University Hospitals provider.
Related Blog Articles
These Pregnancy Complications Are More Common Than You Think
If they happen to you, prompt care is the key to a healthier pregnancy and safer delivery for you and your baby.
Controlling Gestational Diabetes Is Key for Mom and Baby
Gestational diabetes affects up to 10 percent of pregnant women. While it can’t be prevented, it can be controlled to keep both mom and baby healthy.
Pregnancy-Related Conditions Put You at Greater Risk for Cardiovascular Disease Later
Pregnancy-related conditions such as gestational hypertension and gestational diabetes may disappear after childbirth, but they still increase a woman’s risk of developing cardiovascular disease later on in life.
DEET: Best for Preventing Bug Bites, Safe for Pregnant Women
DEET’s benefits are significant because mosquitos and ticks are more than annoyances. They carry a variety of diseases, which can be particularly troublesome for pregnant women.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Joseph Sabik did not disclose any Outside Relationships with Industry.